Press release
15.04.2021 To the attention of interested persons COVID-19 Vaccine Janssen: assessment of very rare cases of unusual blood clots with […]
Press release
15.04.2021 To the attention of interested persons AstraZeneca’s COVID-19 vaccine: EMA to provide further context on risk of very rare […]
Press release
09.04.2021 To the attention of interested persons Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 6-9 April 2021 download […]
Press release
07.04.2021 To the attention of interested persons AstraZeneca’s COVID-19 vaccine: EMA finds possible link to very rare cases of unusual […]
Press release
31.03.2021 To the attention of interested persons AstraZeneca COVID-19 vaccine: review of very rare cases of unusual blood clots continues […]
Press release
25.03.2021 To the attention of interested persons EMA press release: COVID-19 Vaccine AstraZeneca – Update on ongoing evaluation of blood […]
Important notification
25.03.2021 To the attention of interested persons As announced in the Commission BREXIT Notice on medicines in January this year, […]
Press release
22.03.2021 To the attention of interested persons EMA press release: EMA advises against use of ivermectin for the prevention or […]
Press release
18.03.2021 To the attention of interested persons EMA press release: COVID-19 Vaccine AstraZeneca: benefits still outweigh the risks despite possible […]
Press release
15.03.2021 To the attention of interested persons EMA press release: Review of thalassaemia medicine Zynteglo started. download document …